GRAMEGNA, ANDREA
GRAMEGNA, ANDREA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Nonpharmacological interventions for managing infections in chronic respiratory diseases: a comprehensive overview
2026 C. Premuda, M. Santambrogio, S. Misuraca, G. Putti, F. Maraz, A. Sarassi, A. Bulfamante, F. Blasi, A. Gramegna
Beta cell function and insulin sensitivity during elexacaftor/tezacaftor/ivacaftor therapy in people with cystic fibrosis
2026 L. Zazzeron, V. Grancini, M. Trombetta, G. Alicandro, M.L. Boselli, I. Cogliati, G. Mantovani, A. Gramegna, F. Blasi, R.C. Bonadonna, E. Orsi, V. Daccò
Nutritional outcomes in people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftor: A 24-month real-world study
2026 G. Alicandro, L. Zazzeron, V. Visciola, A. Bulfamante, A. Biffi, F. Corti, A. Gramegna, F. Blasi, V. Daccò
Determinants of time to decannulation and predictors of early weaning from tracheostomy: a multicenter, retrospective Italian cohort study
2026 D. Radovanovic, F. Di Marco, M. Mondoni, C. Crimi, A. Gramegna, M. Gatti, J.C. Signorello, F. Raimondi, C. Albrici, G. Morana, F.B.A. Blasi, P. Santus
Prevalence, type, and clinical implications of CFTR variants in bronchiectasis
2026 A. Gramegna, L. Allavena, G. Alicandro, E. Canella, M. Nigro, C. Premuda, M. Ori, M. Santambrogio, L. Porcaro, D. Prati, L. Valenti, S. Aliberti, F. Blasi
Tackling Neutrophilic Inflammation in Bronchiectasis: From Macrolides to Cathepsin C Inhibitors
2026 A. Gramegna, C. Premuda, G. Putti, F. Piedepalumbo, S. Misuraca, M. Ori, M. Nigro, E. Simonetta, S. Aliberti, F. Blasi
Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function: insights from a European multicenter survey
2026 A. Gramegna, C. Magnoni, C. Premuda, G. Alicandro, O. Akkerman, A. Amorim, P. Azevedo, S. Bourke, V. Carnovale, F. Diamantea, L. Fila, F. Frost, R.M. Giron Moreno, C. Pescaru, E. Polverino, A. Felipe Montiel, M. Rachel, G.P. Stoyanova, E. Van Braeckel, S. Volpi, A. Vukić-Dugac, S. Wege, N.J. Simmonds, B.J. Plant, D.G. Downey, S. van Koningsbruggen-Rietschel, P. Burgel, F. Blasi
Bronchiectasis in Italy: an analysis of the EMBARC registry
2026 S. Aliberti, A. Gramegna, E. Simonetta, A. De Angelis, M. Nigro, A. Stainer, F. Amati, S. Battaglia, G. Sotgiu, F. Dente, P. Faverio, O. Sibila, M. Shteinberg, M. Vendrell, K. Dimakou, A. Amorim, E. Polverino, S. Borekci, E. Gerada, J. Pollock, K. Robertson, V. Polelli, M. Santambrogio, M. Retucci, D. Nobile, J.D. Chalmers, F. Blasi
Clinical profile and in-hospital outcomes of patients hospitalised for bronchiectasis exacerbation
2026 F. Bindo, E. Simonetta, A. Gramegna, P. Faverio, P. Scarano, V. Polelli, A. Stainer, F. Amati, M. Nigro, A. Tramontano, S. Mirijaj, P. Curci, M. Mancuso, C. Crimi, F. Luppi, F. Blasi, S. Aliberti
Cystic Fibrosis
2025 S. Misuraca, A. Gramegna, F. Blasi
Impact of elexacaftor/tezacaftor/ivacaftor (ETI) on the prescription refill rate (PRR) for inhaled medications in people with CF: an Italian multicenter analysis
2025 A. Gramegna, G. Cimino, M. Cipolli, G. Gandini, M.A. Calderazzo, A. Profiti, F. Piedepalumbo, F. Blasi
Impact of long-term high-flow nasal therapy on mucus plugs in patients with bronchiectasis
2025 C. Crimi, S. Nolasco, R. Campisi, M. Nigro, P. Impellizzeri, A. Cortegiani, A. Noto, A. Gramegna, C. Vancheri, F. Blasi, N. Crimi, S. Aliberti, A. Carlucci
Guidance for chest-CT in children and adults with cystic fibrosis: A European perspective
2025 M. Fayon, K. Hill, M. Waldron, B. Messore, L. Riberi, M. Svedberg, E. Lammertyn, S. Fustik, A. Gramegna, M. Stahl, A. Kerpel-Fronius, M. Balbi, P. Ciet, G. Chassagnon, C. Ferrero, P. Burgel, S. Sutharsan, M. Opitz, E. Andrinopoulou, G. Dournes, M. Maher, J. Duckers, H. Tiddens, I. Sermet
Alternative splicing and residual function potentially expand the therapeutic landscape of the CFTRdele2ins182 variant
2025 C. Pastorino, L. Menta, E. Pesce, M. Lena, V. Tomati, V. Capurro, M. Di Duca, V. Terlizzi, A. Gramegna, F. Blasi, C. Castellani, S. Cappato, F. Zara, N. Pedemonte, R. Bocciardi
Awareness of respiratory syncytial virus and other respiratory disease vaccines among healthcare professionals and their patients in Italy: Insights from a literature review and a web-based survey
2025 C. Micheletto, G. Lorenzini, S. De Grazia, F. Di Marco, R. Di Matteo, P. Faverio, A. Gramegna, M. Vicentini, F. Blasi
Prevalence and types of treatable traits in bronchiectasis: a multicentre, cross-sectional study
2025 M. Cicchetti, A. De Angelis, E. Simonetta, A. Gramegna, P. Faverio, M. Contarini, F. Amati, V.A. Artuso, A. Tramontano, M. Nigro, P. Scarano, V. Polelli, G.E. Carpagnano, F. Luppi, F. Blasi, S. Aliberti
Limited impact of Elexacaftor/Tezacaftor/Ivacaftor on CPET outcomes in an Italian cohort of people with cystic fibrosis: reinforcing the essential role of exercise training
2025 M. Retucci, A. Gramegna, S. Gambazza, M. Santambrogio, G. Putti, A. Mariani, M.C. Russo, M. Vicenzi, V. Daccò, F. Blasi
How do climate conditions and urbanisation impact nontuberculous mycobacterial infections? An Italian nationwide case–control study
2025 P. Faverio, L. Del Castello, M. Spotti, P. Rebora, E.C. Maggioni, R. Salerno, A. Perotto, F. Luppi, F.R. Bertuccio, S. Reale, V. Fornari, F. Gozzi, B. Granozzi, F.L. Dente, F. Mariotti, J. Simonetti, G. Gualano, N. Riccardi, M. Ferrarese, L.R. Codecasa, G. Sotgiu, A. Gori, A. Gramegna, M. Ori, E. Simonetta, F. Blasi, S. Aliberti
The role of screening for connective tissue diseases in bronchiectasis: an observational study
2025 A. Stainer, M. Nigro, A. Gramegna, E. Simonetta, F. Amati, V. Polelli, A. Tramontano, S. Misuraca, L.C. Morlacchi, F. Blasi, S. Aliberti
Comparison of n-Butyl-2-Cyanoacrylate and Tris-Acryl Microspheres for Bronchial Artery Embolization in Patients with Cystic Fibrosis and Hemoptysis: A Retrospective Cohort Study
2025 A.M. Ierardi, V. Ascenti, A. Gramegna, F. Blasi, C. Del Giudice, G. Xhepa, F. Del Grande, M. Venturini, G. Carrafiello, A. Coppola